InsiderTrades

Form 4 for STOK Stoke Therapeutics, Inc.

Accepted 2025-08-18 00:00:00 ET · period of report 2025-08-14 · accession 0001415889-25-022226 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-08-18 2025-08-14 STOK Allan Jonathan GC, CORP SEC M - OptEx $0.00 +6,000 25.6K +31% $0
D 2025-08-18 2025-08-14 STOK Allan Jonathan GC, CORP SEC M - OptEx $0.00 -6,000 6,000 -50% $0
D 2025-08-18 2025-08-14 STOK Allan Jonathan GC, CORP SEC A - Grant $0.00 +12.0K 12.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-08-14 M A 6,000 $0.00 25,631 D — —
2 Derivative Performance Stock Units 2025-08-14 M D 6,000 $0.00 6,000 D — · — to 2026-08-14 6,000 Common Stock (F1) Each performance stock unit represents a right to receive one share of the Issuer's common stock. (F3) Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.
3 Derivative Performance Stock Units 2025-08-14 A A 12,000 $0.00 12,000 D — · — to 2026-08-14 12,000 Common Stock (F1) Each performance stock unit represents a right to receive one share of the Issuer's common stock. (F3) Half the award vests on August 14, 2025 and the remainder shall vest on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date.